Mitochondrial oxidative phosphorylation reserve is required for hormone- and PPARγ agonist-induced adipogenesis

• Published in: Molecules and cells 2013, 35(2), , pp.134-141
• Main Authors: Ryu, M.J., Chungnam National University School of Medicine, Daejeon, Republic of korea, Kim, S.J., Chungnam National University School of Medicine, Daejeon, Republic of korea, Choi, M.J., Chungnam National University School of Medicine, Daejeon, Republic of korea, Kim, Y.K., Chungnam National University School of Medicine, Daejeon, Republic of korea, Lee, M.H., Chungnam National University School of Medicine, Daejeon, Republic of korea, Lee, S.E., Chungnam National University School of Medicine, Daejeon, Republic of korea, Chung, H.K., Chungnam National University School of Medicine, Daejeon, Republic of korea, Jung, S.B., Chungnam National University School of Medicine, Daejeon, Republic of korea, Kim, H.J., Chungnam National University School of Medicine, Daejeon, Republic of korea, kim, K.S., Chungnam National University School of Medicine, Daejeon, Republic of korea, Jo, Y.S., Chungnam National University School of Medicine, Daejeon, Republic of korea, Kweon, G.R., Chungnam National University School of Medicine, Daejeon, Republic of korea, Lee, C.H., Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea, Shong, M.H., Chungnam National University School of Medicine, Daejeon, Republic of korea
• Format: Article
• Language: English
• Subjects: 3T3-L1 Cells; Adipogenesis - drug effects; adipogenesis,mitochondrial oxidative phosphorylation; Adiponectin - agonists; Animals; Biochemistry; Biomedical and Life Sciences; Biomedicine; Biotechnology; Cell Biology; Cell Cycle Proteins - genetics; Cell Cycle Proteins - metabolism; Cyclooxygenase 1 - metabolism; Ethidium - pharmacology; Fatty Acid Synthase, Type I - metabolism; FOSFORILACION; Gene Knockout Techniques; Life Sciences; Membrane Proteins - metabolism; Mice; Mice, Inbred C57BL; Mitochondria - metabolism; Oxidative Phosphorylation - drug effects; PHOSPHORYLATION; PPAR gamma - agonists; PPAR gamma - genetics; Research Article; Rosiglitazone; Thiazolidinediones - pharmacology; 생물학
• ISSN: 1016-8478; 0219-1032
• DOI: 10.1007/s10059-012-2257-1

Adipocyte differentiation requires the coordinated activities of several nuclear transcription factors. Recently, mitochondria biogenesis was reported to occur during adipocyte differentiation and following treatment with thiazolidinediones in vitro and in vivo. Crif1 is a translational factor for mitochondrial DNA (mtDNA) and is important for transcription of the mitochondrial oxidative phosphorylation (OXPHOS) complex. To investigate the role of OXPHOS in adipogenesis, we analyzed adipocyte differentiation following disruption of Crif1 in vitro and in vivo. The adipose- specific Crif1 knockout mouse had a lower body weight and less fat mass than wild-type mice. Furthermore, adipocytes were smaller and had a dysplastic morphology in the adipose-specific Crif1 knockout mouse. 3T3-L1 adipocytes or adipose-derived stem cells (ADSCs) that lacked Crif1 expressed lower levels of mtDNA-encoded OXPHOS subunits, and adipocyte differentiation was disrupted. Rosiglitazone treatment did not induce adipogenesis or mitochondria biogenesis in Crif1 knockout ADSCs. These results show that mitochondrial OXPHOS and Crif1 are required for rosiglitazone